Single-cell characterization of the immune heterogeneity of pulmonary hypertension identifies novel targets for immunotherapy
We systematically explored the immune heterogeneity and population and target cells in PAH, which may be valuable for developing new and precise therapies.
Authors
- Pan Jiang (ORCID: https://orcid.org/0000-0001-9049-2472)
- Hongyu Shi (ORCID: https://orcid.org/0000-0002-8541-6261)
- Zilong Liu (ORCID: https://orcid.org/0000-0003-1023-177X)
- Mengshi Xie
- Shengyu Hao (ORCID: https://orcid.org/0000-0003-3162-5460)
- Shanqun Li (ORCID: https://orcid.org/0000-0002-8096-9780)
- Lijing Jiang
- Xiaodan Wu (ORCID: https://orcid.org/0000-0002-5622-376X)
- Huai Huang
Institutions
- Sun Yat-sen University (CN)
- Fudan University (CN)
- Zhongshan Hospital (CN)
- The First Affiliated Hospital, Sun Yat-sen University (CN)
- Shanghai Huangpu District Central Hospital (CN)
Publication Details
- Journal
- BMC Immunology
- Published
- 2025-02-10
- DOI
- https://doi.org/10.1186/s12865-025-00684-w
- Citations
- 6
- Primary Topic
- IL-33, ST2, and ILC Pathways
- Type
- article
- Field-Weighted Citation Impact
- 4.78
Funders
- Natural Science Foundation of Shanghai
- National Natural Science Foundation of China